
Ebenezer O. Sackey
Examiner (ID: 17838)
| Most Active Art Unit | 1624 |
| Art Unit(s) | 1613, 1201, 1626, 1624, 1621 |
| Total Applications | 2086 |
| Issued Applications | 1598 |
| Pending Applications | 91 |
| Abandoned Applications | 399 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 14697579
[patent_doc_number] => 10376511
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-08-13
[patent_title] => Pyrazole pyrimidine derivative and uses thereof
[patent_app_type] => utility
[patent_app_number] => 15/748536
[patent_app_country] => US
[patent_app_date] => 2016-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 42
[patent_no_of_words] => 23858
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 361
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15748536
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/748536 | Pyrazole pyrimidine derivative and uses thereof | Aug 3, 2016 | Issued |
Array
(
[id] => 15308885
[patent_doc_number] => 10519133
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-12-31
[patent_title] => Vinyl compounds as FGFR and VEGFR inhibitors
[patent_app_type] => utility
[patent_app_number] => 15/750704
[patent_app_country] => US
[patent_app_date] => 2016-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31568
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 424
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15750704
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/750704 | Vinyl compounds as FGFR and VEGFR inhibitors | Aug 2, 2016 | Issued |
Array
(
[id] => 13986301
[patent_doc_number] => 20190062308
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-28
[patent_title] => 1,3,5-TRIAZINE DERIVATIVE AND METHOD OF USING SAME
[patent_app_type] => utility
[patent_app_number] => 15/748795
[patent_app_country] => US
[patent_app_date] => 2016-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7892
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15748795
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/748795 | 1,3,5-triazine derivative and method of using same | Jul 28, 2016 | Issued |
Array
(
[id] => 13986301
[patent_doc_number] => 20190062308
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-28
[patent_title] => 1,3,5-TRIAZINE DERIVATIVE AND METHOD OF USING SAME
[patent_app_type] => utility
[patent_app_number] => 15/748795
[patent_app_country] => US
[patent_app_date] => 2016-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7892
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15748795
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/748795 | 1,3,5-triazine derivative and method of using same | Jul 28, 2016 | Issued |
Array
(
[id] => 12112742
[patent_doc_number] => 09868723
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-01-16
[patent_title] => 'Mutant-selective EGFR inhibitors and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 15/223343
[patent_app_country] => US
[patent_app_date] => 2016-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12475
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15223343
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/223343 | Mutant-selective EGFR inhibitors and uses thereof | Jul 28, 2016 | Issued |
Array
(
[id] => 13986301
[patent_doc_number] => 20190062308
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-28
[patent_title] => 1,3,5-TRIAZINE DERIVATIVE AND METHOD OF USING SAME
[patent_app_type] => utility
[patent_app_number] => 15/748795
[patent_app_country] => US
[patent_app_date] => 2016-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7892
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15748795
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/748795 | 1,3,5-triazine derivative and method of using same | Jul 28, 2016 | Issued |
Array
(
[id] => 13986301
[patent_doc_number] => 20190062308
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-28
[patent_title] => 1,3,5-TRIAZINE DERIVATIVE AND METHOD OF USING SAME
[patent_app_type] => utility
[patent_app_number] => 15/748795
[patent_app_country] => US
[patent_app_date] => 2016-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7892
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15748795
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/748795 | 1,3,5-triazine derivative and method of using same | Jul 28, 2016 | Issued |
Array
(
[id] => 13328449
[patent_doc_number] => 20180215762
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-02
[patent_title] => TGF BETA RECEPTOR ANTAGONISTS
[patent_app_type] => utility
[patent_app_number] => 15/747843
[patent_app_country] => US
[patent_app_date] => 2016-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19690
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15747843
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/747843 | TGF beta receptor antagonists | Jul 26, 2016 | Issued |
Array
(
[id] => 14664893
[patent_doc_number] => 10370336
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-08-06
[patent_title] => Phenyl-cyanoquinolinone PDE9 inhibitors
[patent_app_type] => utility
[patent_app_number] => 15/745845
[patent_app_country] => US
[patent_app_date] => 2016-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9596
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15745845
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/745845 | Phenyl-cyanoquinolinone PDE9 inhibitors | Jul 26, 2016 | Issued |
Array
(
[id] => 12562839
[patent_doc_number] => 10016515
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-07-10
[patent_title] => DMA, a bis-benzimidazole, confers radioprotection to the intestine via Akt/NFkB dual pathway activation
[patent_app_type] => utility
[patent_app_number] => 15/220631
[patent_app_country] => US
[patent_app_date] => 2016-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 10
[patent_no_of_words] => 11393
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15220631
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/220631 | DMA, a bis-benzimidazole, confers radioprotection to the intestine via Akt/NFkB dual pathway activation | Jul 26, 2016 | Issued |
Array
(
[id] => 15395677
[patent_doc_number] => 10538482
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-01-21
[patent_title] => Adamantane and memantine derivatives as peripheral NMDA receptor antagonists
[patent_app_type] => utility
[patent_app_number] => 15/747507
[patent_app_country] => US
[patent_app_date] => 2016-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 12097
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 191
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15747507
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/747507 | Adamantane and memantine derivatives as peripheral NMDA receptor antagonists | Jul 25, 2016 | Issued |
Array
(
[id] => 17206581
[patent_doc_number] => 11166932
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-11-09
[patent_title] => Stimulators and/or activators of soluble guanylate cyclase (sGC) in combination with an inhibitor of neutral endopeptidase (NEP inhibitor) and/or an angiotensin AII antagonist and the use thereof
[patent_app_type] => utility
[patent_app_number] => 15/746624
[patent_app_country] => US
[patent_app_date] => 2016-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 10846
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15746624
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/746624 | Stimulators and/or activators of soluble guanylate cyclase (sGC) in combination with an inhibitor of neutral endopeptidase (NEP inhibitor) and/or an angiotensin AII antagonist and the use thereof | Jul 14, 2016 | Issued |
Array
(
[id] => 11935097
[patent_doc_number] => 20170239245
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-24
[patent_title] => 'PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS'
[patent_app_type] => utility
[patent_app_number] => 15/209637
[patent_app_country] => US
[patent_app_date] => 2016-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 50085
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15209637
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/209637 | Pyrimidine derivatives for the treatment of viral infections | Jul 12, 2016 | Issued |
Array
(
[id] => 11381543
[patent_doc_number] => 20170007600
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-01-12
[patent_title] => 'ACOUSTIC MIXING FOR AUTO GRANULATION'
[patent_app_type] => utility
[patent_app_number] => 15/204217
[patent_app_country] => US
[patent_app_date] => 2016-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3022
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15204217
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/204217 | Acoustic mixing for auto granulation | Jul 6, 2016 | Issued |
Array
(
[id] => 12008579
[patent_doc_number] => 09801877
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-10-31
[patent_title] => 'AZA spiro alkane derivatives as inhibitors of metalloproteases'
[patent_app_type] => utility
[patent_app_number] => 15/204423
[patent_app_country] => US
[patent_app_date] => 2016-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 51516
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15204423
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/204423 | AZA spiro alkane derivatives as inhibitors of metalloproteases | Jul 6, 2016 | Issued |
Array
(
[id] => 11114811
[patent_doc_number] => 20160311784
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-10-27
[patent_title] => 'CYCLIC TRIAZO AND DIAZO SODIUM CHANNEL BLOCKERS'
[patent_app_type] => utility
[patent_app_number] => 15/201885
[patent_app_country] => US
[patent_app_date] => 2016-07-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21796
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15201885
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/201885 | Cyclic triazo and diazo sodium channel blockers | Jul 4, 2016 | Issued |
Array
(
[id] => 13521935
[patent_doc_number] => 20180312510
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-01
[patent_title] => PHARMACEUTICAL SALTS, PHYSICAL FORMS, AND COMPOSITIONS OF PYRROLOPYRIMIDINE KINASE INHIBITORS, AND METHODS OF MAKING SAME
[patent_app_type] => utility
[patent_app_number] => 15/766736
[patent_app_country] => US
[patent_app_date] => 2016-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21772
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15766736
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/766736 | Pharmaceutical salts, physical forms, and compositions of pyrrolopyrimidine kinase inhibitors, and methods of making same | Jun 29, 2016 | Issued |
Array
(
[id] => 11106155
[patent_doc_number] => 20160303125
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-10-20
[patent_title] => 'DIACYLGLYCEROL ACYLTRANSFERASE 2 INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 15/193440
[patent_app_country] => US
[patent_app_date] => 2016-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 32153
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15193440
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/193440 | Diacylglycerol acyltransferase 2 inhibitors | Jun 26, 2016 | Issued |
Array
(
[id] => 12111847
[patent_doc_number] => 09867824
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-01-16
[patent_title] => 'Heterocyclic compounds and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 15/192491
[patent_app_country] => US
[patent_app_date] => 2016-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 23189
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15192491
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/192491 | Heterocyclic compounds and uses thereof | Jun 23, 2016 | Issued |
Array
(
[id] => 13492929
[patent_doc_number] => 20180298007
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-18
[patent_title] => PYRAZOLO[1,5-A]TRIAZIN-4-AMINE DERIVATIVES USEFUL IN THERAPY
[patent_app_type] => utility
[patent_app_number] => 15/737907
[patent_app_country] => US
[patent_app_date] => 2016-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10124
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15737907
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/737907 | Pyrazolo[1,5-a]triazin-4-amine derivatives useful in therapy | Jun 9, 2016 | Issued |